Vlasveld, L. T., Hekman, A., Vyth-Dreese, F. A., Rankin, E. M., Scharenberg, J. G., Voordouw, A. C., . . . Melief, C. J. (1993). A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part II: Immunological aspects. Nature Publishing Group.
Citação norma ChicagoVlasveld, L. T., et al. A Phase I Study of Prolonged Continuous Infusion of Low Dose Recombinant Interleukin-2 in Melanoma and Renal Cell Cancer. Part II: Immunological Aspects. Nature Publishing Group, 1993.
Citação norma MLAVlasveld, L. T., et al. A Phase I Study of Prolonged Continuous Infusion of Low Dose Recombinant Interleukin-2 in Melanoma and Renal Cell Cancer. Part II: Immunological Aspects. Nature Publishing Group, 1993.